246 related articles for article (PubMed ID: 20616688)
1. Clinical factors related to visual outcome in central serous chorioretinopathy.
Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
[TBL] [Abstract][Full Text] [Related]
2. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
[TBL] [Abstract][Full Text] [Related]
3. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
Yalcinbayir O; Gelisken O; Akova-Budak B; Ozkaya G; Gorkem Cevik S; Yucel AA
Retina; 2014 Apr; 34(4):705-12. PubMed ID: 24100708
[TBL] [Abstract][Full Text] [Related]
4. Foveal thickness can predict visual outcome in patients with persistent central serous chorioretinopathy.
Furuta M; Iida T; Kishi S
Ophthalmologica; 2009; 223(1):28-31. PubMed ID: 18849634
[TBL] [Abstract][Full Text] [Related]
5. Early changes in foveal thickness in eyes with central serous chorioretinopathy.
Hata M; Oishi A; Shimozono M; Mandai M; Nishida A; Kurimoto Y
Retina; 2013 Feb; 33(2):296-301. PubMed ID: 23023530
[TBL] [Abstract][Full Text] [Related]
6. Correlations among various functional and morphological tests in resolved central serous chorioretinopathy.
Kim SW; Oh J; Huh K
Br J Ophthalmol; 2012 Mar; 96(3):350-5. PubMed ID: 21617156
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
[TBL] [Abstract][Full Text] [Related]
11. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy.
Matsumoto H; Sato T; Kishi S
Am J Ophthalmol; 2009 Jul; 148(1):105-10.e1. PubMed ID: 19327740
[TBL] [Abstract][Full Text] [Related]
12. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
13. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.
Suh MH; Seo JM; Park KH; Yu HG
Am J Ophthalmol; 2009 Mar; 147(3):473-480.e3. PubMed ID: 19054492
[TBL] [Abstract][Full Text] [Related]
14. Central serous chorioretinopathy.
Marcuson J; Riley T
Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
[TBL] [Abstract][Full Text] [Related]
15. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
[TBL] [Abstract][Full Text] [Related]
16. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.
Piccolino FC; de la Longrais RR; Ravera G; Eandi CM; Ventre L; Abdollahi A; Manea M
Am J Ophthalmol; 2005 Jan; 139(1):87-99. PubMed ID: 15652832
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
[TBL] [Abstract][Full Text] [Related]
18. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.
Chen SN; Hwang JF; Tseng LF; Lin CJ
Ophthalmology; 2008 Dec; 115(12):2229-34. PubMed ID: 19041477
[TBL] [Abstract][Full Text] [Related]
19. Correlation of fundus autofluorescence gray values with vision and microperimetry in resolved central serous chorioretinopathy.
Oh J; Kim SW; Kwon SS; Oh IK; Huh K
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):179-84. PubMed ID: 22159007
[TBL] [Abstract][Full Text] [Related]
20. [Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography].
Yu H; Xia GY; Gao MH; Yu J; Zhang YY
Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):508-15. PubMed ID: 21914265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
